19
Participants
Start Date
August 6, 2021
Primary Completion Date
April 10, 2023
Study Completion Date
August 30, 2023
Placebo
Starting the last day of oral vancomycin (Day 1), subjects randomized to this arm will take 5 capsules of placebo for 14 days taken once daily.
VE303
"Starting the last day of oral vancomycin (Day 1), subjects randomized to this arm will take 5 capsules of VE303 taken daily for 14 days.~The quantity of each strain is proportioned to assure a specific per-strain per-capsule titer. The 8 strains are blended together with a micro-crystalline cellulose flow agent and placed in enteric capsules."
oral vancomycin
All enrolled subjects will receive 5 days of oral vancomycin 125 mg four times a day (q.i.d).
University of Michigan, Ann Arbor
Lead Sponsor
Vedanta Biosciences, Inc.
INDUSTRY
American College of Gastroenterology
OTHER
American Association for the Study of Liver Diseases
OTHER
Patricia Bloom
OTHER